Menlo Therapeutics, Inc.
(NASDAQ : MNLO)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
JNJJohnson & Johnson
1.27%142.230.7%$1094.25m
PFEPfizer Inc.
0.70%43.810.9%$892.61m
MRKMerck & Co., Inc.
-0.76%84.720.6%$748.60m
BMYBristol-Myers Squibb Company
0.94%49.071.4%$533.89m
LLYEli Lilly and Company
0.57%115.891.0%$486.49m
ABBVAbbVie, Inc.
1.55%78.812.2%$357.28m
NVSNovartis AG Sponsored ADR
0.65%92.510.2%$199.25m
AZNAstraZeneca PLC Sponsored ADR
0.31%41.811.2%$117.75m
GSKGlaxoSmithKline plc Sponsored ADR
-0.72%40.710.2%$89.35m
SNYSanofi Sponsored ADR
0.02%44.090.2%$87.18m
NVONovo Nordisk A/S Sponsored ADR Class B
-2.44%51.140.1%$77.06m
LCILannett Company, Inc.
0.00%5.6836.6%$4.60m
AKTXAkari Therapeutics Plc Sponsored ADR
-5.02%2.081.6%$0.42m
EPIXESSA Pharma Inc
3.27%2.380.1%$0.01m

Company Profile

Menlo Therapeutics Inc. operates as biopharmaceutical company which is focused on the development and commercialization of serlopitant for the treatment of pruritus, or itch, associated with dermatologic conditions such as atopic dermatitis, psoriasis and prurigo nodularis. The company was founded in October, 2011 and is headquartered in Redwood City, CA.